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ABSTRACT

Three homeobox transcription factors were studied for their importance in
eye development - rax1, pax6, and six3. Rax1 encodes transcription factors that
regulate genes necessary for the development of the eye. I show that perturbation of
rax1 expression via morpholino mediated translational knockdown has no affect on the
shape of pax6 and six3 expression domains at early stages. Significant pax6 expression
changes were only seen at later stages of development. This inverts the hierarchal
model of these transcription factors in early eye development. Furthermore, to confirm
the position of these genes in our model we examined the relationship of significant eye
field markers - namely, foxe3, 𝞬-crystallin, pitx3, mafA, and otx2. By knocking down rax1
and observing the outcome on the eye field markers I established that rax1 is a major
contributor but downstream to the overall process of eye development.
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CHAPTER 1
Introduction

Embryogenesis requires genes to turn on in a systematic manner and to interact
with each other in order to properly assemble cells, tissues, and organs. Xenopus laevis
serves as a magnificent model for studying organ development at the embryonic level.
For example, Xenopus provides an abundance of eggs that can be simultaneously
fertilized externally, allowing for systematic observation of processes through the early
stages of embryonic development. There is a century-long tradition of eye studies in
amphibians (Reviewed in Fabler, 1996), and therefore an abundance of techniques and
reagents available to study the genes that regulate eye development.

Specifically, this model organism has been helpful in studying induction of the
eye. The eye is the product of inductive interactions between underlying neural tissue
and the presumptive head ectoderm, ultimately leading to the formation of the optic cup
and the lens (Henry et. al, 2002). In Xenopus, lens induction occurs in two phases. The
first phase is known as the early phase and takes place during gastrulation, from stages
10-12 of development (Nieuwkoop & Faber). The ectoderm is capable of responding to
neural cues during stage 11. The second phase of lens induction is known as the late
phase, and it occurs when the optic vesicles bulge sufficiently to come into contact with
the overlying head ectoderm at around stage 19 (Henry et. al., 2002). During this phase,
the site of lens formation is specified in the head ectoderm consequently allowing for
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induction and differentiation from both lens ectoderm and retina neural tissue (Henry et.
al., 2002).

Eye Development

The first morphological sign of eye development in the vertebrates is a bilateral
evagination of the diencephalon. As the evagination of the optic primordia proceeds,
optic vesicles are formed and extend towards the non-neural surface ectoderm.
Interposed between the surface ectoderm and neural structures of most of the head,
mesenchyme presents a physical barrier to interaction in all places except the areas of
presumptive lens and cement gland. When optic vesicles (neural) and ectoderm come
into direct contact, inductive signals are exchanged between them (Chow and Lang,
2001).

The first morphological sign of the presumptive lens is formation of the lens
placode (Figure 1.1). The lens placode involves columnarization of the surface
ectodermal cells immediately above the optic vesicle. The optic vesicle and lens
placode induce invagination behaviours in each other causing the lens vesicle and a
double-layered optic cup to form. This produces the first indication of the final shape of
the eye in vertebrates (Chow and Lang, 2001). The pigmented retina is formed by
differentiation of the outer layer of the optic cup, whereas the inner layer gives rise to
the neural retina (Lang, 1999). The ectoderm contributes to the lens placode and
overlying ectoderm, and differentiates into lens and cornea, respectively.
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Figure 1.1: An overview of eye development. A) Neural tube closure leads to direct
contact between the optic vesicles and pre-lens ectoderm that thickens to form a
placode (red). B) The lens placode invaginates and induces the optic cup (orange). C)
The lens vesicle separates and is placed in the cavity formed by the invagination of the
optic cup. D) Lens, neural retina, and cornea are essentially formed and as the retinal
cup pinches off from the diencephalon, an optic stalk is formed that encloses the optic
nerve (adapted and modified from the Brown et. al., 2011).

Differentiation and Proliferation in Eye Development

During early eye development, a population of proliferative, undifferentiated
precursors is necessary prior to differentiation of the organ. Neural differentiation in
Xenopus begins immediately after gastrulation, however, at this point, only the anterior
neural plate is specified. Subsequently the neural plate rolls up to form a tube, and at
the anterior end, it begins to balloon to form presumptive brain. It is important that the
retinal progenitor cells of the neuro-ectoderm that are located in the optic vesicles
undergo several cycles of proliferation to provide a population sufficient to differentiate
into diverse populations of cells within the retina. We know that differentiation events
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occurring in retinal progenitor cells (RPCs) are tightly linked to proliferation (Nelson et
al., 2009).

During the G1 phase of the cell cycle, the retinal progenitor cells face a decision
to continue with proliferation or to differentiate (Ohnuma et al., 1999). The decision to
differentiate is one-way, causing the cell to enter the G0 phase; cells are prevented from
re-entering the cell cycle. During the G1 phase there are specific, active Cyclin/CyclinDependent Kinase (CDK) enzyme complexes, namely CyclinD:CDK4/6 and
CyclinE:CDK1/2, that help to mediate whether proliferation or differentiation is to occur
(Duparc et al., 2007). However, there are also CDK inhibitors present that may influence
the activity of the CDK enzyme complexes. In Xenopus, only the Cip/Kip family of CDK
inhibitors has been identified (Su et al., 1995).

For eye morphogenesis to occur, a minimal threshold of proliferating cells is
required in the anterior neural plate (Nelson et al., 2009), and this requires active
suppression of differentiation. Expression of hairy2 and zic2 are typically positively
regulated by the rax1 gene, and both act as anti-neurogenic transcription factors (Ando
et al., 2005). p27XicI is a cell cycle inhibitor that is also suppressed by rax1 which
ultimately promotes proliferation. Furthermore, rax1 represses the expression of proneural genes xdelta-1 and xngnr-1, preventing the differentiation of competent cells.
Suppression of rax1 confirms these observations: activation of an engrailed repressor
chimera. Rax1-enR, causes inhibition of rax1 targets which leads to the expansion of
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the pro-neural genes in the anterior neural plate. This reduces proliferation and induces
neuralization, ultimately reducing the size of the eye field (Andreazzoli et al., 2003).

Studies have shown that level of cyclinD1, which is a major cyclin enzyme in the
retinal progenitor cells, are significantly increased when there is an over-expression of
rax1 by mRNA injections. Furthermore, the expression of p27Xic1 is simultaneously
inhibited by rax1 over-expression (Casarosa et al., 2003). The other eye field
transcription factors, six3 and six6, both bind to the promoter of p27Kip1, ultimately
inhibiting its activity and inducing proliferation (Li et al., 2002). Furthermore, six3
regulates cyclinD1 and p27 expression levels (Gestri et al., 2005). Therefore, the
assortment of eye field transcription factors involved in eye development regulate
several cell cycle and differentiation parameters during eye development.

Dorsoventral Patterning of the Eye by BMP4

Dorso-ventral patterning of the eye is under the influence of bmp4, a ventralizing
agent that serves as an antagonist to the activation/transformation of ectoderm to
neuroectoderm (Schmidt et al., 1995). When bmp4 is over-expressed in Xenopus
embryos, ventralization results which leads to suppression of neuroectoderm. This
conversion from neural to epidermal fates is caused by a reduction in the competence
of tissues to respond to neuralizing cues from the underlying mesoderm (Nakayama et
al., 1998).
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Inhibition of bmp4 is essential for neural plate induction and, ultimately, for the
development of the neural component of the eye field. This is demonstrated by explant
studies in mice where over-expression of bmp4 in the presumptive lens ectoderm can
suppress lens development (Furuta and Hogan, 1998). In bmp4 null mutant mice,
explants of presumptive lens ectoderm forms normal lens and induces retina when
transplanted on wild-type optic vesicles, but when bmp4 is present the isolated
ectoderm fails to form lens (Furuta and Hogan, 1998). Furthermore, bmp4 null mutant
mice do not survive past E10.5, demonstrating how important this gene is to dorsalventral axis maintenance (Furuta and Hogan, 1998).

Not surprisingly then, bmp4 also represses the expression of major neural
markers. These neural markers, rax1, pax6, and otx2, are repressed when bmp4 coated
beads are implanted surgically into the anterior neural plate region during mid-neural
stages (Hartley et al., 2001). Furthermore, bmp4 that is expressed ectopically using a
pax6 promotor suppresses rax1 and otx2. Additionally, bmp4 was found to repress the
dorsalizing pathway that is required for the optic cup and lens formation (Hartley et al.,
2001).

Genes Involved

As described above, there are several genes involved in the regulation of eye
development in Xenopus, some of which commence expression during gastrulation at
stage 10.5. Among these genes are otx2 and six3 which play a major role in eye field
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expression, as opposed to rax1, pax2, and pax6 sub-domains which are confined to
areas within the larger domains of otx2 and six3. The domains of these early eye field
transcription factors overlap during expression: sox2 is expressed along the neural tube
and in the eye field domain where rax1, pax6, and six3 overlap (Figure 1.2).

Figure 1.2: A schematic summarizing the expression of Eye Field Transcription Factors
involved in early invertebrate eye development.

Homeobox Factors

The most studied genes involved in eye development are the homeobox genes
that demonstrate the most spectacular mutant phenotypes including rax1, pax6, pitx3,
otx2, and six3. The homeobox sequence found within these genes encodes a protein
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domain known as the homeodomain. This protein domain is 60 amino acids long and
contains motifs that recognize a TAAT consensus target sequence (Beebe et. al, 1994).

Rax1

Rax1 is an eye field transcription factor that has a homeodomain sequence which
shares a high homology with the paired-like genes (Kamijyo et. al., 2014). The core
homeodomain sequence of rax1 binds to a TAAT consensus motif (Terada et al., 2006).
Rax1 RNA is expressed in the forebrain region where the optic vesicles are formed
(Giudetti et. al., 2014). Rax1 expresses prior to pax6 expression and in coordination
with six3 (Oliver et al., 1995). The rax1 gene is involved in the development of the
retina, pineal gland, pituitary gland, and hypothalamus (Kamijyo et. al., 2014).

Rax1 is heavily involved in eye development in Xenopus where it begins its
expression during the stages following gastrulation. It is initially expressed at stage 10
of development (Zuber et. al., 2003), but is especially prominent at stage 13 and
continues to express throughout, until stage 45, well after eye development completes
and expression begins to decline. Expression of rax1 is detectable during the
development of the optic vesicle, before contact is made with the overlying ectoderm.
This takes place around stages 16 and 17.

The significance of rax1’s role in eye development has been highlighted in
research due to the phenotypes that result from mutations in the rax1 gene. These
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mutations lead to defects in the eye which have been characterized in mice and
humans. In mice, the eyeless (ey1) mutant phenotype lacks eyes and/or optic tract. This
naturally occurring phenotype is due to a mutation in the start codon of murine rax1
gene (Tucker et al., 2001). In humans, mutations found in the homeodomain of the
RAX1 gene have led to microphthalmia and anophthalmia. Individuals who suffer from
microphthalmia are characterized by reduced eye size, whereas those who suffer from
anophthalmia show a lack of eyes (Voronina et al., 2004). Conversely, in Xenopus,
over-expression of the rax1 gene has been shown to cause an enlarged retinal pigment
epithelia (Mathers et al., 1997).

Rax1 interaction with the pax gene family is heavily researched due to the
similarity of their respective mutant phenotypes, as well as the overlapping patterns and
timing of their expression domains (Zuber et al., 2003). The pax6 gene is involved in
eye development and, like rax1, is expressed in the retinal field and the anterior neural
plate (Mathers & Jamrich, 2000). In the later stages of eye development, pax6
expression leads to lens and retina development while expression of rax1 appears to be
more specifically responsible for retinal development. An interesting interaction between
rax1 and pax6 has been observed in which individuals expressing a rax1 mutant
phenotype lack the structures of the lens even though rax1 is not expressed in the lens
(Swindell et al., 2008). According to research conducted by Zuber and his colleagues,
rax1 activates pax6 expression, resulting in the development of lens structure (Zuber et
al., 2003). However, by co-injecting pax6 mRNA with six3 morpholino, Saqib Sachani
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found that pax6 rescues the expression of rax1 (Sachani, 2011; Current study). This
leads us to speculate that rax1 expression is driven by pax6, not the reverse.

Pax6

The pax6 gene is a paired-like transcription factor belonging to the Pax family. It
encodes two DNA binding motifs, a homeodomain and the paired box (Stuart et al.,
1994). Pax6 is commonly known as the master regulator of eye development and is vital
for retina and lens development. Mutations of the PAX6 gene leads to the human
disorder known as aniridia. Mutations of the Pax6 gene are also found in mice and
Drosophila, where a mutation can lead to small eye (sey) in mice and an eyeless
phenotype in Drosophila (Chow and Lang, 2001). The Pax6 heterozygous mutant
observed in mice is characterized by the small eye (sey) phenotype, ultimately resulting
in hypoplasia of the iris, cataracts, and microphthalmia (Hill et al., 1991). However, mice
that are Pax6 null mutants tend to be anophthalmic and generally die at birth (Grindley
et al., 1995).

Pax6 plays a major role in Xenopus eye development. It is first expressed at
stage 10 (Zuber et. al., 2003) and is then later expressed in the retina and presumptive
lens. Pax6 is also involved in development of the brain and is expressed in the neural
tube. It is expressed in the neuroepithelial cells at stage 14, where these cells
eventually give rise to pigmented and neural retinas. During eye development, pax6 is
expressed throughout stages 12.5 to 28, where the lens begins to thicken and becomes
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distinct from the overlying epithelium after stage 28. Expression of pax6 in the lens
remains relatively high up to stage 33. Once stage 42 of development is complete, pax6
expresses solely in the inner nuclear and the ganglion cell layers of retina (Harris &
Hirsch, 1997). Ectopic pax6 expression in Xenopus leads to formation of a fully
differentiated ectopic eye, as well as enhanced expression of eye field markers, namely
rax1, six3, and otx2 (Chow et al., 1999).

Six3

The six3 gene is a transcription factor found in Xenopus that is homologous to
the sine oculis (so) gene in Drosophila. It is part of the Six family and has cloned
homologues in human, avian, mouse, and fish (Oliver et al., 1995). Six3 expression in
mice is first detectable in lens placode, followed by expression in the lens epithelium
during further developmental stages (Oliver et al., 1995). The six3 sequence encodes
the DNA binding homeodomain, as well as a Six domain that mediates interaction with
other transcription factors (Oliver et al., 1995). Six3 itself lacks the ability to activate
these genes in the absence of a partner (Otho et. al., 1999). Six3 is a crucial gene in
Xenopus eye development, beginning as a maternal transcript onward at stage 10.5
during gastrulation (Zuber et. al. 2003). The expression domain for six3 is located in the
anterior end of the neurula in neuroectoderm, at stage 14. During stage 20, the midregion of the ventral diencephalon shows heavy expression of six3 which then migrates
anteriorly towards the telencephalon. Expression is then limited mainly to the eye region
and the ventral diencephalon between the eyes at stage 32 (Ghanbari et al., 2001).
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Mutations of the six3 gene and its homologues is of common interest in Xenopus
and other species. Mutations of the homologous fly so gene leads to retinal
degeneration as well as premature development of the optic lobe (Serikaku & O’Tousa,
1994). In medaka fish, over-expression of six3 causes enlarged optic vesicles and
expansion of the presumptive midbrain (Wittbrodt et al., 1999). Gene knockdown
experiments were performed on medaka fish by use of six3 morpholinos and
abnormalities were found in the development of craniofacial, forebrain, and eye
structures. When morpholino concentrations were increased, small eyes, cyclopic eyes
and, eventually, complete absence of eyes resulted (Wittbrodt et al., 2002). In mice,
Six3 null mutant embryos show a loss of telencephalic regions and are characterized by
craniofacial anomalies (Oliver et al., 2008). In both human and mouse mutants,
holoprosencephaly occurs to different degrees leading to microphthalmia or cyclopia
(Lacbawan et al., 2009).

Pitx3

Pitx3 is a member of the paired-like homeodomain family of genes, and it is
expressed in several areas in Xenopus, including the brachial arches, otic vesicles,
pituitary, the presumptive lens ectoderm, the somites, and the heart and gut. It is
expressed in the mid-blastula, around stages 9-11.5, as well as during early
gastrulation. Expression increases after the mid-neural stages, expressing through
stages 12-19, which covers the late phase of induction (Khosrowshahian et al., 2005).
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Pitx3 is believed to express before the lens placode thickens, and it is maintained in the
lens placode, as well as the lens vesicle and the lens pit. Expression of pitx3 in the prelens and lens-tissue is high from stage 19-34, where the strongest expression is viewed
at stage 24 in competent ectoderm when it is in contact with the optic vesicle
(Khosrowshahian et al., 2005). At this stage the expression is marked at the
presumptive lens ectoderm, but once the presumptive lens ectoderm develops into the
lens placode, expression of pitx3 is strongest in the lens placode. Eventually,
expression in eye is restricted to the lens epithelial layer as development reaches later
stages (Pommereit, Pieler, & Hollemann, 2001).

Experiments of pitx3 inhibition in Xenopus embryos via morpholino knockdown
impaired eye development, resulting in reduced eyes, or even inhibiting them entirely
when the concentration of morpholino was high (Khosrowshahian et al., 2005). When
pitx3 is over-expressed, however, the pax6 domain expands, suggesting that pax6 may
be under the control of pitx3 in the lens. Conversely, during pitx3 knockdown
experiments in whole embryos, expression of pax6 tends to be down-regulated. It is
also believed that pitx3 regulates expression of rax1, foxe3, and otx2 (Khosrowshahian
et al., 2005). Mutations of Pitx3 in mice and humans have also been observed. PITX3
mutation in humans cause abnormal cornea displacement, underdeveloped iris, pupil
displacement, multiple pupillary openings, and the development of congenital cataracts
(Semina et al., 1998; Espinoza et. al., 2002). Deletion of Pitx3 in mice leads to aphakia
which is characterized by small eyes without lenses (Semina et al., 2000).
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Otx2

The otx2 gene is a homeobox gene that is related to the orthodenticle family of
genes (Simeone et al., 1993). Otx2 in Xenopus embryos is detectable as a maternal
transcript. Expression levels of otx2 during blastula stages are low but detectable
nonetheless. Otx2 expression is visible in the eye field at stage 10.5 in the mid-gastrula
embryo and is activated before most of the other eye field transcription factors
(Simeone et al., 1993). After gastrulation, expression of otx2 is also limited to the
anterior dorsal region of the embryo, where it restricts to the mesendoderm and the
anterior ectoderm regions after gastrulation has taken place (Boncinelli et al., 1995).
Otx2 and rax1 have been shown to have some interplay in eye development, but in situ
hybridization experiments determined that their early expression domains were quite
different (Andreazzoli et al., 1999), suggesting the interplay must occur at later stages
or be indirect. Otx2 is inhibited by over-expression of rax1, indicating that otx2 is not
needed for eye field specification in early stages of development since rax1 overexpressing embryos still form eyes. Possibly, six3 is active and can carry on this role,
although it is necessary for the specification of the anterior neural domains (Andreazzoli
et al., 1999).

Following morpholino-mediated otx2 knockdown experiments in Xenopus,
unusual anterior development and deformed eyes were observed (Carron et al., 2005).
By contrast, when otx2 is over-expressed, the result is induction of the ectopic cement
glands as well as abnormally large eyes (Gammil and Sive, 1997). Homologs of the
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otx2 gene are found in humans and mice and are vital for early specification of the
neuroectoderm when it transitions to mid- and forebrain (Simeone, 1998). Deletion of
the Otx2 gene in mice causes lethal defects during gastrulation. Mice that are Otx2 null
mutants are characterized by missing midbrain and forebrain structures, most likely due
to abnormal neural induction (Pannese et al., 1995).

Pax2

Pax2, like pax6, contains the highly conserved DNA binding domain known as a
paired domain which is encoded by the paired-box (Pichaud and Desplan, 2002).
Interestingly, pax2 also has an octapeptide domain which pax6 does not posses,
categorizing it as a multi-functional transcription factor (Eccless et. al., 2002). Although
pax2 does not hold the same evolutionarily conserved role in eye development as pax6,
it still has an important role in the process. Pax2 is first detectable in the developing
optic cup and then, following invagination, is limited to glial cells which extend to form
the optic stalk (Macdonald and Wilson, 1998). Other than being expressed in the eyes,
pax2 is also expressed in the otic vesicle primordium and specifies regions in the
central nervous system (CNS) and kidney (Quinn et. al., 1996; Tavassoli et. al., 1997).

Optx2

Optx2 is a homeobox gene and a member of the six family. Optx2 plays an
important role in early regulation of retinal development as well as interacting with other
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transcription factors in regulating cell proliferation of the retina. The optx2 homolog in
Xenopus is the xoptx2 gene and is first detected at stage 15 as a single band on the
anterior edge of the developing neural plate until it reaches around stage 17, when
expression begins to extend laterally. At stage 18, xoptx2 expression separates into two
regions that are consistent with the eye field locations. Stages 20-22 sees the
expression become limited to the developing eye primordia. Expression of xoptx2 is
detected in the cells of the protruding primary optic vesicles (stage 24). The vesicles
invaginate at stage 28 to form the optic cup where expression is still strong in the
developing retina, but is not visible in the thickening ectodermal lens placode. xoptx2
expression is still detectable at stages 33 and 34 in the developing neural retina, but
slowly begins to diminish thereafter (Zuber et al., 1999).

Optx2 plays a vital role in the overall size of the developing eye and brain of
Xenopus embryos. Over-expression also caused an enlargement of the eye field which
is believed to be due to an increase in the progenitor population, which is expected if
the eye bud is enlarged. Xoptx2 also increased the size of rax1’s expression domain in
embryos at stage 17. This was also the case with Pax6 and tbox3 (formerly known as
ET), the domains of which increased within the eye field at stage 17. Ectopic overexpression of xoptx2 induced an enlarged eye, where folding of the neural retina was
also visible. Xoptx2 knockout experiments resulted in Xenopus embryos with
significantly reduced eyes, and sometimes eliminated eye formation. Reducing the
expression of xoptx2 also led to a significant reduction in the expression domain of rax1.
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These effects are similar in other vertebrates and their homolog genes (Zuber et al.,
1999).

Lhx2

Lhx2 is a member of the LIM-homeodomain transcription factor family which is
structurally characterized by a carboxy terminal homeodomain, as well as two amino
terminal zinc-finger motifs. lhx2 is one of the various eye field transcription factors that is
essential for eye development. In Xenopus, lhx2 expression is detected at stage 12.5 in
the neuroectodermal layer of the anterior plate in the location of the eye field. At this
stage, the expression is visible as a single band but diverges into the two eye primordia
at stage 18 when the optic vesicles begin to form. At stage 24, lhx2 expression is
detected in the presumptive retinal epithelium, the neural retina, and the optic stalk.
However, once the lens begin to form around stage 28, expression is absent from the
lens placode but is still visible in the neural retina and the presumptive retinal pigment
epithelium. Lhx2 continues to express in all cells of the developing retina until retinal
progenitors start to differentiate, which occurs at around stage 41. At this stage,
expression becomes limited to the ciliary marginal zone and a selected group of cells in
the inner nuclear layer (Viczian et al., 2006).

Homologues of Lhx2 are found in mice and Drosophila. In mice, the Lhx2 gene is
essential for eye development. Lhx2 mutant mice lack eyes even though the optic
prominences evaginate normally from the brain. The optic vesicles never form, thus no
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eye forms. In Drosophila, the lhx2 homologue is likely the selector gene apterous (ap).
The expression pattern of ap is very similar to lhx2. In fact, experiments have shown
that human lhx2 can rescue the fly mutant ap phenotype (Rincon-Limas et al., 1999).
Typically, the inactivation of eye field transcription factors in Drosophila leads to eyeless
flies.

Sox Transcription Factors

The sox genes are part of the High Mobility Group (HMG) proteins which are
transcription factors that have the HMG domain, a 75 amino acid DNA-binding domain.
These genes play a significant role in eye development in Xenopus, mice, and chick.
First to express is the sox1 gene in the lens placode area, later limiting expression to
the lens fibre cells. Sox2 is first expressed in the anterior neural plate region at around
stage 14 in Xenopus, but is then found to express along the developing neural tube and
eventually in the anterior dorsal head region at stage 19. Sox2 expression is also
noticeable during the later phase of eye development in the PLE region, as well as the
optic cup. It’s expression is significantly higher during thickening of the lens placode
(Kamachi et al., 1998). Expression of sox3 takes places in the lens placode region as
well, occurring during induction, playing a role in the activation of crystallins (Kamachi et
al., 1998). It has been found that de novo mutations of the Sox2 gene lead to the
absence of eyes in mammals (Ragge et al., 2005).
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MafA Leucine Zipper Transcription Factors

MafA is part of the maf family of leucine zipper transcription factors and plays a
role in lens induction, placode thickening and differentiation. There are several members
of the Maf family including mafA, mafB, and c-maf. MafA is mainly seen to be expressed
in the lens ectoderm as opposed to mafB which is expressed primarily in the optic
vesicle anlagen (Ishibashi and Yasuda, 2001). MafA is expressed around stage 24 of
development in the lens placode during presumptive lens ectoderm induction and
differentiation. It is also observed to up-regulate expression of the crystallin genes. In
Xenopus embryos, as well as chick embryos, mafA over-expression causes ectopic
induction of crystallin in the presumptive lens ectoderm. In contrast to mafA, mafB is
expressed at stage 20, during induction by the optic vesicle. It is believed to induce the
expression of mafA in the presumptive lens ectoderm. Both mafA and mafB can
substitute for the other’s function if need be: if mafB is knocked down in embryos, mafA
mRNA expression rescues the activation of the crystallins (Ishibashi and Yasuda, 2001).

Forkhead Factors

The family of forkhead (or winged-helix) transcription factors display a wide
variety of functional diversity with respect to developmental processes. They are
involved in cell growth, lens progenitor cell proliferation, and cell cycle regulation,
amongst many other cellular processes (Carlsson & Mahlapuu, 2002). Forkhead
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transcription factors have a DNA binding domain called the forkhead box which allows
them to bind to DNA as monomers (Kaestner et. al., 2000).

Foxe3

Foxe3, also commonly known as lens1, is a transcription factor which is part of
the sub-family of the forkhead family and is notably recognized as a winged-helix motif
(Kaufmann & Knochel, 1996). Generally speaking, the expression pattern of foxe3 is
limited to the lens lineage (Blixt et. al., 2000). In Xenopus, foxe3 acts to promote
proliferation and sustain an undifferentiated state prior to lens specification. Shortly after
lens specification is completed, foxe3 increasingly limits expression from the
presumptive lens ectoderm to the lens placode and then to the epithelium of the
differentiating lens. When foxe3 is ectopically over-expressed in Xenopus there is
complete suppression of lens differentiation which is reflected by a total loss of 𝞬crystallin expression. Foxe3 appears to maintain the ectoderm when expression levels
are high, but this is occurring in an undifferentiated manner. Once the differentiation of
the lens takes place, foxe3 expression drops while sox2 and sox3 are positively
regulated in the presumptive lens ectoderm, followed by progressive differentiation.

Crystallins

Crystallins are structural proteins of the lens and are key members of the heat
shock protein superfamily (Ghosh et. al., 2005). They are involved in stress response
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and cellular protection, and their expression signals the terminal differentiation of lens
fibre cells (Wistow & Piatigorsky, 1998). Crystallin proteins are abundant in the lens,
constituting over 90% of lens proteins (Clark, 2004). They have structural qualities that
are important for transparency and refracting light (Jaffe & Horwitz, 1992). There are a
few categories of crystallins, but the most commonly discussed ones are ⍺-crystallins,
β-crystallins, and 𝞬-crystallins (Wistow & Piatigorsky, 1998).

⍺-crystallins are a family comprised of ⍺-A-crystallin and ⍺-B-crystallin, which are
present in the lens in a 3:1 ratio. These two make up roughly 40% of the crystallins
found in the lens. β-crystallins and 𝞬-crystallins both derive from a common ancestor
and have two types of Greek key motifs, which are anti-parallel β-sheets fused together
(Bax et. al., 1990; Blundell et. al., 1981). 𝞬-crystallins exist only as monomers because a
compact complex forms between domains. This tight, condensed structure allows 𝞬crystallin to provide transparency by folding in a regulated state (Lubsen et. al., 1998).
However, the expression levels of both β-crystallins and 𝞬-crystallins vary among
different species regardless of their structural similarities.

In Xenopus embryos, both ⍺-crystallins and 𝞬-crystallins are expressed in the
developing lens vesicle and show high levels of expression throughout the
differentiation of the lens fibre (Van Leen et. al., 1987). Further in development, βcrystallin expression is evident in the lens fibre cells. The crystallins are in active form
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through primary lens fibre differentiation to secondary lens fibre formation (Treton et. al.,
1991).

The genes discussed above are listed below in Table 1, summarizing their
functions in eye development. There is an overlapping pattern of expression
characterized by these eye field transcription factors, but their functional expression is
divided into subunits of the eye. These subunits are: the optic stalk, pigmented retina,
neural retina, and the lens (see Figure 1.3).
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Table 1: A summary of genes involved in lens and eye development with their important
functions

Gene

Function

Rax1

- Development of retina and optic vesicles
- Proliferation
- Inhibitor of differentiation markers/cell cycle exit

Pax6

-

Six3

- Inhibitor of BMP4
- Activator of Pax6 and Sox2
- Lens differentiation

Sox2

- Regulator of crystallin expression
- Lens fibre differentiation
- Proliferation

Otx2

- Inhibitor of BMP4
- Lens competence
- Neural bias

BMP4

- Promotes ventral fate
- Dorsoventral eye patterning

Foxe3

- Proliferation

Pitx3

- Retina and lens induction

MafA

- Crystallin activation
- PLE induction
- Lens differentiation

𝞬-crystallin
Pax2

Lens epithelium maintenance
Crystallin expression
Eye field specification
Establishing lens bias

- lens differentiation and development
- RPC proliferation
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Figure 1.3: A schematic showing the various transcription factors expressing in different
tissues of the eye. The proximal end (left) shows the early expressed markers, the distal
end (right) shows the late expressed markers; NR - Neural Retina (Adapted and
modified from Saqib Sachani).
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My Project

Eye development has been extensively studied over the years and is still a
growing field with plenty of research required. Zuber and his colleagues developed a
model for eye field specification and lens induction where otx2 primarily drives neural
patterning (Figure 1.4). His research also suggests that there is a feedback loop
between secondary eye field transcription factors such as pax6, rax1, and six3 in which
these genes are expressed after the early expression of otx2. From their developed
model they concluded that rax1 inhibits expression of otx2 and that rax1 is upstream of
six3 and pax6.

Figure 1.4: The model proposed by Zuber and colleagues showing a summary of the
eye field induction in the anterior neural plate in which rax1 is driving the expression of
both pax6 and six3 (adapted and modified from Zuber et. al., 2003).
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Zuber’s early model requires revision and further research on the eye field
transcription factors involved in eye development. Six3 and otx2 have been found to be
the earliest expressed genes during late gastrulation and both are expressed before
rax1 prior to anterior neural plate definition (Chow and Lang, 2001; Zuber et al., 2003).
Therefore, it is not yet clear how rax1 in Zuber’s model can serve as the primary initiator
in the hierarchy since it appears to express so late. Furthermore, six3 and otx2 mutants
have more severe phenotypes in the eye and other brain structure. In contrast, rax1
mutant phenotypes are localized more specifically in the eye region. Otx2 null mutants
in mice displayed missing forebrain and midbrain structures, most likely due to
abnormal neural induction (Pannese et al., 1995). In Xenopus, morpholino-mediated
knockdown of otx2 led to severe eye and anterior development abnormalities (Carron et
al., 2005). Knocking down six3 in medaka fish led to abnormalities found in the
development of craniofacial, forebrain, and eye structures. Increasing morpholino
concentrations resulted in small eyes, cyclopic eyes and, eventually, complete absence
of eyes (Wittbrodt et al., 2002). Six3 null mutant mice exhibited a loss of telencephalic
regions and were characterized by craniofacial anomalies (Oliver et al., 2008). In
Xenopus, six3 perturbation also resulted in abnormal craniofacial development such as
improper neural closure, reduced or lost forebrain, and a complete loss of eye
structures (Sachani, 2011). These findings contradict Zuber’s model and suggest that
rax1 is downstream of otx2 and six3 in eye development.

Our lab has developed results which contradict Zuber’s intelligent model through
knockdown, rescue, and over-expression experiments on six3 and pax6 followed by in
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situ hybridization to examine the effect on other eye field transcription factors and eye
marker genes. Six3 morpholino-mediated knockdown inhibits pax6 expression at early
and late stages of eye development. Conversely, over expression six3 results in
enhanced pax6 protein levels (Sachani, 2011). Furthermore, six3 knockdown led to
complete inhibition of rax1 expression at stage 19, when rax1 is normally expressed in
the anterior neural plate. Knocking down pax6 did not effect six3 expression domain at
early stages of development, but did reduce the eye field domain of six3 at late stages
(Sachani, 2011). Ectopic pax6 expression expanded the expression domain of six3 at
early to mid neurula stages, suggesting pax6 feeds back on six3 at those stages. This
might be a direct interaction, but it is also possible that the effect is indirect.
Enhancement/enlargement of the eye field by ectopic pax6 might increase the number
of cells present in the organ, thereby increasing six3 domain.

Similar to six3, pax6 morpholino-mediated knockdown results in complete
abolishment of rax1 expression in the anterior neural plate and presumptive eye field
(Sachani, 2011). Conversely, pax6 over-expression resulted in expanded rax1
expression domain. Interestingly, when six3 morpholino is co-injected with pax6 mRNA,
rax1 expression is rescued to normal and is even slightly over-expressed on the
injected side. This indicates pax6 is likely operating upon rax1 downstream of six3 and it
is also consistent with the finding that in the absence of six3, pax6 is inhibited and rax1
is then down-regulated as a result (Sachani, 2011). Morpholino-mediated knockdown
experiments for six3 also revealed deleterious effects on other eye genes: otx2, pitx3,
foxe3, mafA, 𝞬-crystallin, pax2, and sox2 all exhibited a significantly reduced expression
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domains or complete inhibition of expression. Pax6 knockdown yielded the same result
except that it did not have any affect on otx2 expression (Sachani, 2011). These findings
led our lab to propose model which is still under investigation (Figure 1.5). Nonetheless,
it situates six3 upstream of pax6 and rax1 in contrast to Zuber’s model which shows
rax1 being upstream of pax6 and six3, in that order (Figure 1.4).

My project will focus primarily on the role of rax1 in eye development and its
interaction with other previously studied eye field transcription factors. In order to
evaluate and understand the functional role of rax1, knockdown experiments will be
conducted by use of microinjected morpholino oligonucleotides that is directed against
rax1 mRNA. The effect rax1 knockdown has on six3 and pax6 will help confirm that rax1
is downstream of six3 and pax6 and reveal more about the relationship between rax1
and foxe3, pitx3, 𝞬-crystallin, mafA and otx2. Over-expression and rescue experiments
will also be conducted. Over-expression will involve co-injecting rax1 mRNA with a
lineage marker GFP and determining the effect on foxe3, pitx3, and 𝞬-crystallin
expression. Three rescue experiments will be attempted: 1) anti-rax1 morpholino mRNA
(pm298) and GFP will be co-injected with a rax1-specific morpholino, 2) six3 mRNA will
be co-injected with GFP and rax1 morpholino, and 3) pax6 mRNA will be co-injected
with GFP and rax1 morpholino. The rescue experiments are to determine if expression
of foxe3, pitx3, and 𝞬-crystallin is rescuable by pm298, six3, and pax6. Whole-mount in
situ hybridizations will be conducted to characterize the phenotypes that result and to
study the interaction associated with rax1 and these eye field genes.
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Figure 1.5: The proposed model derived by Crawford and colleagues (unpublished;
Sachani, 2011) and from relevant literature showing gene interaction in eye
development. This model demonstrates that pax6 expression is driven by six3 and that
rax1 expression is driven by pax6 directly and six3 indirectly.
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CHAPTER 2
Rax1 is crucial for normal eye morphology and is downstream of six3 and pax6

In the past, gain- and loss-of-function, as well as animal cap and whole embryo
RT-PCR assays were employed to determine the hierarchal role of three Eye Field
Transcription Factors during eye development. Based upon studies in Xenopus, rax1 is
presently understood to stand upstream of six3 and pax6 (Zuber et. al., 2003). By
contrast, members of our lab have shown that six3 appears to work upstream of both
pax6 and rax1 (Sachani, 2011). The outcome of rax1 knockdown experiments on eye
field markers - foxe3, pitx3, 𝞬-crystallin, mafA, and otx2 - will confirm rax1’s role in eye
development. Furthermore, over-expression of rax1 and rescue experiments involving
an anti-rax1 morpholino mRNA, as well as pax6 and six3 rescue experiments will
solidify the hierarchal order of these genes. These findings will help us establish the
roles of six3, pax6, and rax1 and understand their hierarchal order in eye development
in Xenopus laevis.

Morpholino-mediated rax1 translation knockdown should faithfully reproduces the
characteristic small-eye phenotype seen in mammals. However, rax1 knockdown is not
expected to affect the expression of six3 or pax6 at early stages of development. Since
pax6 is an intermediary of rax1 and six3, down-regulation of rax1 should only affect the
expression pattern of pax6. Our studies show that six3 is upstream of both pax6 and
rax1 (Sachani, 2011). Rax1 is rescued by ectopically administering pax6 mRNA upon
six3 knockdown (Sachani, 2011). Therefore, six3 is expected to be unaffected by rax1
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knockdown. In addition to translational knockdown, over-expression of rax1 will provide
further understanding of the interactions rax1 has on eye field genes. Furthermore, it is
necessary to perform rescue experiments and determine whether the expression of
these genes can be restored upon rax1 morpholino-mediated knockdown. Since rax1,
six3, and pax6 are the priority transcription factors under investigation for my project,
using their mRNA to rescue expression of the other genes must be carried out.
However, a plasmid that contains the rax1 insert but excludes the rax1 morpholino sites
must be designed to avoid knocking down rax1 expression when performing the rescue
experiment. Six3 and pax6 mRNA will be co-injected with rax1 morpholino to determine
if they are able to rescue the expression of eye field genes. If rax1 is indeed
downstream of pax6 and six3, mRNA of pax6 and six3 shouldn’t be able to rescue rax1
morpholino knockdown.
Before reporting the outcome rax1 knockdown produces, it is imperative to
confirm the specificity of the rax1 morpholino used to rule out off-target and toxic effects.
Two rax1 morpholinos - Rax1.1 and Rax1.2 - were unilaterally injected in Xenopus
embryos at 2-cell stage; the contralateral un-injected side serves as a control.
Phenotypes were expected to resemble fish, murine, and human mutant phenotypes. To
further confirm specificity, three control morpholinos were also used: Rax1.1b mismatch
control, Rax1.2 mismatch control, and a Fluorescent Standard Control. Rax1.1b control
and Rax1.2 control are similar in sequence to experimental morpholinos but with five
nucleotide sequence mismatches. Unilateral injection of these control morpholinos
should produce normal eye phenotypes. A synergistic injection which combines Rax1.1
and Rax1.2 morpholinos at lower concentrations was carried out to determine if the
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same phenotype is produced which confirms the specificity of said morpholinos. Upon
confirming specificity, the optimal morpholino dose required to produce a consistent
phenotype needed to be determined. This was done by unilaterally injecting rax1
morpholino into a 2-cell embryo at a range of concentrations and observing what
dosage produces the expected phenotype without resulting in off-target or toxic effects.
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Materials and Methods

Xenopus laevis
African clawed frogs (Xenopus laevis) were delivered from Xenopus I, Inc.
(Michigan, USA). Rearing of frogs followed the regulations of the University of Windsor’s
Animal Care Committee (ACC), as well as Federal and Provincial regulations. To induce
ovulation, an adult female frog was injected with 0.75 cc of Human Chorionic
Gonadotrophin (HCG) hormone (Sigma-Aldrich, Ontario, Canada). Once eggs were
obtained, fertilization and de-jellying eggs followed the protocol outlined by Drysdale
and Elinson (1991). Embryos were staged according to Nieuwkoop and Faber and fixed
in MEMPFA, followed by storage in 70% methanol at -20oC.

Rax1 Rescue Clone - Plasmid 298 (pm298)
The rax1 cDNA minus the rax1 morpholino binding sites was amplified using
Phusion high fidelity DNA polymerase (NEB). The insert was cloned into the XhoI site of
pCS2+. Initial denaturation was 94oC for 2 minutes, followed by denaturing at 94oC for
45 seconds. Annealing temperature was set at 67oC for 45 seconds followed by
extension at 74oC for 30 seconds for 26 cycles. The sequence for the forward primer is:
GATCCTCGAGAGGGTCCTCAATGCACCTGCACA and the sequence for the reverse
primer is: GATCCTCGAGGCTCGAGAGGCCTTGAATTC. The amplicon was purified
and digested with XhoI before being ligated into the XhoI site of pCS2+. pm298
encodes the ORF of rax1 but does not include the 5’ UTR binding sites for Rax1.1 and
Rax1.1 morpholinos. Therefore, when the pm298 transcript is co-injected a rax1
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morpholino, it can still undergo translation, generating a normal phenotype. The rescue
clone generated (pm298) was confirmed by bi-directional sequencing (Robarts
Research Institute London, Ontario.

Morpholinos
Two fluorescein-tagged morpholino oligonucleotides (MO) (directed against rax1)
were designed and ordered from Gene Tools, LLC (Orlando, Florida). The first
morpholino is Rax1.1 and its sequence targeting the 5’ UTR rax1 region is 5’
CTTGAGGTGTTCAATCACGATGATT 3’. The second morpholino is Rax1.2 and its
sequence is 5’ CTTTATCTGATCGTGCTTAGTAGTC 3’.
Three fluorescent morpholino controls were used to confirm specificity of the rax1
morpholinos; these three are Rax1.1b CO, Rax1.2 CO, and a Fluorescence Standard
Control. The Fluorescence Standard Control is a generic 3’-Carboxyfluoroscein
morpholino designed by the manufacturer which controls for morpholino and fluoroscein
effects (5’ CCTCTTACCTCAGTTACAATTTATA 3’). The sequence for the Rax1.1b CO
morpholino is: 5’ CTTGAGCTCTATCATGACCATCATT 3’. The sequence for the Rax1.2
CO morpholino is: 5’ CTTTATGTCATCGTCCTAACTAGTC 3’.

Microinjection
All injections made into the fertilized embryos were performed using a
Drummond nano-injector. Whether it was a morpholino or mRNA being injected, the
volume injected into each embryo was constant at 4.6nL and was injected into the
animal pole of the embryos at either the 1-cell stage, or the 2-cell stage unilaterally,
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targeting one of the blastomeres. During injection, the embryos were submerged in 2%
Ficoll-400 and 0.3x MBS to allow them to heal. They were placed in the incubator at
12oC for a minimum of 60 minutes before transferring them to 0.1x MBS solution.
Replacing the 0.1x MBS twice a day was crucial for embryos health. The concentration
for the majority of morpholino injections was 10ng; rescue experiments were performed
using 50pg transcription factor RNA and 150pg of GFP RNA as a tracer.

Whole-mount in situ hybridization
In situ hybridization techniques were performed essentially as per Smith and
Harland (1991) using digoxigenin labeled probes synthesized by previous graduate
students. Post in situ hybridization, images were captured using a camera attached to a
Leica N2FL III stereoscope and Northern Eclipse software. See APPENDIX B for full
protocol
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Results
Rax1 plays a crucial role in eye development. Six3 expression is independent of
rax1 at early-to-late stages of eye development.
In order to confirm the role of rax1, the translation of rax1 mRNA was knocked
down through morpholino injections. Several concentrations were tested for two rax1
morpholinos, Rax1.1 and Rax1.2. To control for off-target effects, morpholino specificity
was tested by: 1) assessing if the same phenotype was achievable using two different
morpholino target sequences; 2) determining if low concentrations of the two
morpholinos synergized to mimic the phenotype of higher concentrations of either
alone; 3) mismatch morpholino controls produced no phenotypic effects; 4) a
commercially designed fluorescent control morpholino with no similarity to Xenopus
sequences proved innocuous. Data characterizing the phenotypes displayed from rax1
morpholinos, as well as controls, was collected (Tables 2 and 3). Based upon images in
Figure 2.1 (A-C), we see that the knockdown of rax1 causes an outcome where the eye
produced is a small eye phenotype (B). At higher concentrations we see that the
dorsoventral patterning of the eye, as well as the eye itself, is abolished (C).

Rax1 morpholino was injected unilaterally into Xenopus embryos, allowing the
un-injected side to serve as a control. Following a series of riboprobe in situ
hybridization experiments where a six3 probe was used, it appeared that the six3
expression domain is unaffected by rax1 being knocked down at earlier stages and
slightly later stages of eye development (Figure 2.1: D-F). This solidifies the proposed
model where rax1 is downstream of six3.
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Table 2: Effect of rax1.1 morpholino mediated knockdown with percentages of
phenotypes observed for different morpholino concentrations injected.
Morpholino specificity of rax1 morpholinos and rax1 control morpholinos tested at an
optimal MO dose. Rescue experiments that combine pax6 mRNA with rax1 MO, six3
mRNA with rax1 MO, and pm298 mRNA with rax1 MO. All rescues included GFP mRNA
as a tracer. Phenotypic consequences can compound and so percentages sum to more
than 100%. All embryos were unilaterally injected and grown to stage 37/38 for
examination.
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Table 3: Effect of rax1.2 morpholino mediated knockdown with percentages of
phenotypes observed for different morpholino concentrations injected.
Morpholino specificity of rax1 morpholinos and rax1 control morpholinos tested at an
optimal MO dose. All embryos were unilaterally injected and grown to stage 37/38 for
examination.
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Figure 2.1: Rax1 expression is important for normal eye morphology. Six3
expression and maintenance is independent of rax1 activity
A-C) Embryos were examined at stage 37/38 of development. When injected with 5ng
of rax1 morpholino, retinal development is only slightly affected as seen by the
development of the retina (A). Increasing the concentration to 10ng shows a small-eye
phenotype (B). At 20ng morpholino concentration we see abnormal dorsoventral
patterning and an almost complete loss of retinal development (C).
D-F) Whole-mount in situ hybridization of rax1-MO injected embryos probed with six3.
Three stages were examined: 14 (D), 19 (E), and 27 (F). The expression domain of six3
is unaffected by rax1 mediated knockdown at all three stages. White arrows in images
indicate the injected side of the embryo and are highlighting the expression pattern of
the injected side, specifically the eye field region. The un-injected side of the embryo is
opposite of the dashed line and is showing normal expression of six3.
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Pax6 is upstream of rax1 but downstream of six3. Pax6 is affected by rax1
knockdown at a later stage in development.
After unilateral injections of rax1 morpholino, embryos at stages 14, 19, and 27
were collected and examined by whole-mount in situ hybridization with a pax6 probe. In
Figure 2.2 A and B, (stages 14 and 19, respectively) pax6 expression domains appear
to be normal when compared to the un-injected (control) side. However, at later stages,
in the eye field domain of pax6 was slightly reduced (Figure 2.2 C). This suggests that
late stage pax6 is dependent on rax1 expression for continued activation and
maintenance. It also shows that rax1 indirect-deficit alters the size and number of cells
in which pax6 expresses.
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Figure 2.2: Pax6 expression could be indirectly affected by rax1 during later
stages of eye development
A-C) Whole-mount in situ hybridization of rax1-MO injected embryos probed with pax6.
Three stages were examined: 14 (A), 19 (B), and 27 (C). The expression domain of
pax6 is unaffected by rax1 mediated knockdown at earlier stages of development (A,B).
However, at stage 27 (C) the expression domain of pax6 is slightly reduced where the
arrow is pointing. Arrows in images indicate the injected side of the embryo and are
highlighting the expression pattern of the injected side, specifically the eye field region.
The un-injected side of the embryo is opposite of the dashed line and is showing normal
expression of pax6.
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Rax1 regulates eye marker genes further downstream: knocking down rax1
results in decreased expression pattern for foxe3 (lens1)
Rax1 is a key marker in the early stages of eye development as it is expressed
throughout the anterior neural plate, as well as expressing in the optic vesicles during
later stages (Gestri et. al., 2005). Rax1 is crucial for specification at early stages of
development which is followed by proliferation of the retinal progenitor cells
(Andreazzoli et al., 1999). Foxe3 (commonly known as lens1) promotes proliferation
and sustains an undifferentiated state prior to lens specification. After specification,
foxe3 limits expression from the presumptive lens ectoderm to the lens placode and
then to the epithelium of the differentiating lens.

Following unilateral rax1 morpholino injection, the expression pattern for foxe3
appeared to be completely abolished in the presumptive lens region (Figure 2.3 A).
Furthermore, when rax1 mRNA was injected there was an increase in foxe3 expression
(Figure 2.3 B). This relationship is better understood when pm298 is co-injected with
with rax1 morpholino. Due to the absence of rax1 morpholino binding sites in pm298,
rax1 mRNA is available for translation. Consequently, foxe3 expression is rescued and
even slightly over-expressed (Figure 2.3 C). Interestingly, this is not the case when
either pax6 or six3 mRNA is co-injected with rax1 morpholino. Foxe3 expression
remains highly perturbed (Figure 2.3 D,E). However, pax6 and six3 still rescue eye
morphology as a whole according to our findings in Table 2.
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Figure 2.3: Rax1 alters expression of foxe3 during eye development, specifically
in the lens
A) Whole-mount in situ hybridization of rax1-MO injected embryos probed with foxe3 at
stage 27 of development. The expression domain of foxe3 is clearly missing in the
injected side by rax1 mediated knockdown, specifically where the lens placode would
normally develop (indicated by smaller white arrow).
B) Whole-mount in situ hybridization of a stage 27 embryo injected with rax1 mRNA and
probed with foxe3. The eye field indicated by the smaller white arrow shows overexpression of foxe3.
C-E) Whole-mount in situ hybridization of rescue experiments probing for foxe3. C)
Unilateral co-injection of pm298 mRNA and rax1-MO shows that the expression domain
of foxe3 is restored and slightly over-expressed as indicated by the white arrow. This,
however, is not the case when pax6 or six3 are co-injected with rax1-MO (D,E). In both
D and E, we see that foxe3 expression is not rescued at all in the eye field region
(smaller white arrow).
White arrows in images indicate the injected side of the embryo and are highlighting the
expression pattern of the treated side. Black arrows indicate an un-injected side of the
embryo, opposite of the dashed line, showing normal expression pattern (untreated) of
foxe3.
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Rax1 has an effect on pitx3 and 𝞬-crystallin expression patterns: six3, pax6 and
rax1 are interacting to regulate downstream genes
Pitx3 is expressed in the presumptive lens ectoderm and is a major player in the
lens induction process (Khosrowashahian et. al., 2005). 𝞬-crystallins are expressed in
the developing lens vesicle and show high levels of expression throughout the
differentiation of the lens fibre (Van Leen et. al., 1987). Both genes show highest
expression around stages 24-27 of development. When rax1 was knocked down, we
found that the expression domains for both pitx3 and 𝞬-crystallin were completely
abrogated (Figure 2.4 A; Figure 2.5 A). When rax1 mRNA is injected, the result is slight
over-expression of pitx3 and 𝞬-crystallin in the injected side (Figure 2.4 B; Figure 2.5
B).

Furthermore, rescue experiments are imperative to clarify the interaction of rax1,
six3, and pax6 on these downstream genes. Co-injecting pm298 mRNA with rax1-MO
successfully rescues both pitx3 and 𝞬-crystallin expression (Figure 2.4 C; Figure 2.5
C). Pax6 has been proven to be necessary for normal expression of both genes. Pax6
mRNA was able to restore pitx3 and 𝞬-crystallin expression patterns almost completely
(Figure 2.4 D; Figure 2.5 D). The same outcome was observed when six3 mRNA was
co-injected with rax1-MO, showing almost completely rescued expression domains in
the lens for both pitx3 and 𝞬-crystallin (Figure 2.4 E; Figure 2.5 E).
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Figure 2.4: Rax1 has an affect on pitx3 expression pattern
A) Whole-mount in situ hybridization of rax1-MO injected embryos probed with pitx3 at
stage 27 of development. The expression domain of pitx3 is abolished in the injected
side by rax1 mediated knockdown, specifically in the lens region of the eye field (smaller
white arrow).
B) Whole-mount in situ hybridization of a stage 27 embryo injected with rax1 mRNA and
probed with pitx3. The injected side shows slight over-expression of pitx3 in the eye
field region, as indicated by the smaller white arrow.
C-E) Whole-mount in situ hybridization of rescue experiments probing for pitx3. C)
Unilateral co-injection of pm298 mRNA and rax1-MO shows that the expression domain
of pitx3 is restored and slightly over-expressed in the entire eye field (smaller white
arrow). Pitx3 expression in the eye field is somewhat restored when pax6 or six3 are coinjected with rax1-MO (D,E). In both D and E, we see that pitx3 expression is present in
the eye field (white arrows) but not to normal amounts (black arrows).
White arrows in images indicate the injected side of the embryo and are highlighting the
expression pattern of the treated side. Black arrows indicate an un-injected side of the
embryo, opposite of the dashed line, showing normal expression pattern (untreated) of
pitx3.
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Figure 2.5: Rax1 knockdown disrupts 𝞬-crystallin expression
A) Whole-mount in situ hybridization of rax1-MO injected embryos probed with 𝞬crystallin at stage 27 of development. The expression domain of 𝞬-crystallin is abolished
in the injected side, specifically in the lens (smaller white arrow) by rax1 mediated
knockdown, confirming the absence of differentiating lens.
B) Whole-mount in situ hybridization of an embryo injected with rax1 mRNA and probed
with 𝞬-crystallin. The smaller white arrow shows slight over-expression of 𝞬-crystallin in
lens compared to the control side (black arrow).
C-E) Whole-mount in situ hybridization of rescue experiments probing for 𝞬-crystallin. C)
Unilateral co-injection of pm298 mRNA and rax1-MO shows that the expression domain
of 𝞬-crystallin is restored and slightly over-expressed in the eye (smaller white arrow).
This is also the case for six3 when co-injected with rax1-MO (white arrow) (D). In E, we
see that 𝞬-crystallin expression is completely rescued in lens by pax6 mRNA (smaller
white arrow).
White arrows in images indicate the injected side of the embryo and are highlighting the
expression pattern of the treated side. Black arrows indicate an un-injected side of the
embryo, opposite of the dashed line, showing normal expression pattern (untreated) of
𝞬-crystallin.

59
Effects on notable eye marker genes after rax1 knockdown
I looked at the effect of rax1 on other eye marker genes, namely otx2 and mafA,
through rax1 morpholino-mediated knockdown experiments. Following rax1 translational
knockdown, otx2 expression is slightly reduced in the anterior neural plate and the eye
field (Figure 2.6 B). Knocking down rax1 shows the same effect on mafA by reducing its
expression in the lens (Figure 2.6 A). mafA can directly induce the expression of 𝞬crystallin (Kataoka et. al., 2007) which is also affected by rax1 knockdown. I also
unilaterally injected a rax1 control morpholino for a visual comparison of the effects on
both eye marker genes. The mismatch control morpholino produced no affect on otx2 or
mafA.
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Figure 2.6: Rax1 knockdown effects observed for otx2 and mafA eye marker
genes
Rax1 morpholino was unilaterally injected in Xenopus embryos to study the effects that
rax1 knockdown has on two notable eye marker genes. A rax1 control morpholino was
also unilaterally injected to serve as another control, showing no effect on expression
patterns in the injected side. Black arrows are used to show the injected side of the
embryo and highlight any changes in expression levels. The expression of mafA in lens
(A) is slightly reduced as indicated by the black arrow. The expression of otx2 in the
anterior-dorsal region and eye field is abolished (B) as highlighted by the black arrow.
A & A’: MafA
B & B’: Otx2
rax1-MO: Rax1 morpholino
rax1 CO MO: Rax1 control morpholino
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Discussion

Many studies have examined the roles of Eye Field Transcription Factors
(EFTF’s), specifically the relationship of rax1 with upstream and downstream eye field
markers (Zuber et. al., 2003; Muranishi et. al., 2012; Andreazzoli et. al., 2003; Giudetti
et. al., 2014; Kamijyo et. al., 2015). Although extensive research has been done on
these genes, their interaction with one another and hierarchal relationships are still
unclear. I am proposing an alternative model based on results found by past and
present work outlined in my thesis (Figure 3.1). Ultimately, this will help us understand
the inductive patterns of the main transcription factors associated with eye development
and put to bed debate concerning the hierarchal order of these genes.
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Figure 3.1: A model summarizing the eye field genes and their functional roles in eye
development, derived from studies in our lab and relevant literature. This model
demonstrates the complexity of signalling cascades involved in eye development and
the possible pathways in which these genes interact. Dashed lines signify a potential
feedback role that is suggested by the data but not yet to be confirmed.
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Rax1 expression is necessary for normal eye development

Understanding the molecular pathways controlled by rax1 and its interaction with
other eye field transcription factors is necessary to unraveling the basic mechanisms of
eye development as a whole. Previous studies have highlighted the importance of rax1
in different organisms. Loss of the Rax genes in mice resulted in reduced optic vesicles
and also provided abnormal forebrain phenotypes (Muranishi et. al., 2012). In humans,
RAX gene mutations are associated with microphthalmia and anophthalmia (Bailey et.
al., 2004). Furthermore, in Xenopus and zebrafish, rax1 over-expression causes
extensive proliferation of retinal cells (Terada et. al., 2006). Conversely, rax1 was
suppressed via morpholino-mediated knockdown in zebrafish (Nelson et. al., 2009).
Moreover, Terada et. al. (2006) found that rax1 morpholino-mediated knockdown
experiments reveal a reduced eye size in Xenopus embryos; this is confirmed by work
done in our lab.

Using antisense morpholino oligonucleotides directed against the rax1 translation
start site, I determined that knocking down rax1 expression in Xenopus embryos
reduces the size of the eye, characterized as small-eye phenotype. Lower
concentrations of morpholino produce minor effects on eye development, with some
dorsoventral abnormalities. Increasing morpholino concentrations, however, result in
significant reduction of the eye field and at high enough concentrations can cause total
loss of eye structures. My results are consistent with previous findings mentioned above
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and emphasize the significance of rax1 in eye development (Andreazzoli et. al., 2003;
Terada et. al., 2006).

The specificity of the morpholinos was confirmed and can be viewed in Tables 2
and 3. The two experimental morpholinos Rax1.1 and Rax1.2 were injected unilaterally
in 2-cell embryos and examined at stage 37/38 of development. Both morpholinos
produced the same phenotype consistently when injected at a range of concentrations.
Rax1.1b mismatch control and Rax1.2 mismatch control were injected at two dosages,
10ng and 20ng. Both controls produced no effects on eye morphology, suggesting the
phenotypic effects produced by Rax1.1 and Rax1.2 morpholinos are not because of offtarget or toxic effects. To further confirm specificity of the morpholinos, a low dose
synergistic injection was conducted. Rax1.1 and Rax1.2 were co-injected at lower
doses along with a Fluorescent Standard Control morpholino that does not carry a
sequence found in Xenopus. The synergistic injection provided the same results as
Rax1.1 and Rax1.2 morpholinos produced when injected at a higher dose individually.
This suggests the two morpholinos are specific in blocking the translation of rax1 to
produce the phenotypes observed when each morpholino is unilaterally injected.

Three different rescue experiments were carried out: 1) mRNA of an anti-rax1
morpholino plasmid named pm298 was co-injected with the rax1 morpholino; 2) pax6
mRNA was co-injected with rax1 morpholino; 3) six3 mRNA was co-injected with rax1
morpholino. Examining the phenotype of unilateral 2-cell injected embryos at stages
37/38 exhibited normal eye morphology (Table 2). Therefore, the eye developed
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normally which confirms the specificity of the morpholinos since the mRNA injected was
able to translate properly.

Rax1 is downstream of six3 and does not directly regulate six3 expression in
early eye development

Both rax1 and six3 are responsible for stimulating proliferation (Zuber et. al.,
2003). Neural differentiation begins in the posterior neuro-ectoderm following
gastrulation. Eye field progenitor cells continuously proliferate in order to reach high
populations sufficient to produce an eye. Pro-neural differentiation genes are inhibited in
the presumptive eye field by rax1 expression which is dependent on pax6 and six3
activity (Gestri et. al., 2005; current study). Six3 is necessary in early development for
the proliferation of cells in the anterior neural plate by promoting rax1 enhancement
(Andreazzoli et. al., 2003). Previous work done in our lab has shown that six3
knockdown results in loss of rax1 expression in the anterior neural plate region
(Sachani, 2011). This is most likely via an indirect route to pax6 levels being reduced.

To confirm this hierarchy and further understand rax1’s effect on the other
markers, we knocked down rax1 and examined the outcome it has on six3 expression.
Three stages of development were observed: stage 14, 19, and 27. Our results show
that six3 expression is unaffected at all three stages when rax1 is knocked down. This
contradicts results found by Zuber et. al., (2003) who were working with cultured animal
cap explants - ectopic cultures of ectodermal tissues removed during gastrulation and
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analyzed at stages equivalent to neurula. Rax1 enhances proliferation and when overexpressed in animal caps produces high numbers of optic progenitor cells, leading to
greater expression of six3 (Zuber et. al., 2003). However, there are more constraints in
whole embryos and ventral factors are most likely playing a dominant role. Our data
suggests that pax6 plays an intermediary role between rax1 and six3 (Figure 3.2).

Figure 3.2: A summary model of the genes involved in eye development highlighting the
placement of rax1 and six3 in the cascade (red). Rax1 is downstream of six3 based on
my findings and those of Sachani (2011). Dashed lines signify a potential feedback role
that is suggested by the data but not yet to be confirmed.
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Rax1 regulates pax6 expression only at later stages of eye development

Pax6 mRNA over-expression has led to expansion of the expression domain for
rax1 in the anterior neural plate, specifically in the eye field (Sachani, 2011). This finding
implies that pax6 is working either directly or via other key factors to enhance rax1
expression (current study) and is confirmed by pax6 occupancy of rax1 promoter
(Thakurela et. al., 2016). Co-injecting six3 morpholino with pax6 mRNA results in almost
complete rescue of rax1 expression, telling us that six3 is upstream of pax6, and that
pax6 is in turn likely upstream of rax1. Therefore, the real inhibition by six3 knockdown
is likely due to the secondary effect of pax6 expression being reduced. It is very likely
that pax6 has a role in activating rax1 early in development in order to promote
proliferation (Blixt et. al., 2000; current study).

These findings unambiguously situate pax6 between six3 and rax1. Interestingly,
rax1 has a regulatory role on pax6. When rax1 is knocked down at stages 14 and 19
there is no apparent affect, however at stage 27 of development, the expression domain
of pax6 appears to be slightly reduced. It is possible that rax1 regulates pax6 in late
embryogenesis directly or via intermediaries such as otx2 (Thakurela et. al., 2016).
Alternatively, rax1 mis-regulation may affect the number of cells in presumptive organs
indirectly, altering the domains of transcription factors such as pax6 (Current study).
Since rax1, six3, and pax6 have overlapping expression domains, it is likely that pax6 is
relying on rax1 activity during later stages in order for pax6 to continue regulating other
downstream genes - namely, pitx3, foxe3, 𝞬-crystallin, and mafA. Therefore, rax1, six3,

69
and pax6 may refine and support each other’s expression domains differentially in a
stage dependent manner. It is likely there are other players and this triad is but a part of
a more complicated network where other genes cross-regulate each other (Figure 3.3).

Figure 3.3: A summary model of the genes involved in eye development highlighting the
placement of rax1 and pax6 in the cascade (red). Rax1 is downstream of pax6 based
on my findings and those of Sachani (2011). Pax6 appears to be intermediary of six3
and rax1. Dashed lines signify a potential feedback role that is suggested by the data
but not yet to be confirmed.
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Rax1 is necessary for foxe3 activation

Foxe3 is normally expressed in the lens. Although foxe3 is not involved in lens
differentiation per se, it initiates a lens forming bias in the presumptive lens ectoderm
(Kenyon et. al., 1999). Furthermore, foxe3 induces proliferation of lens progenitor cells
which go through differentiation in the posterior region of the lens (Kenyon et. al., 1999).
Previous work in our lab has shown pax6 and six3 knockdown experiments result in
complete loss of foxe3 expression in the lens (Sachani, 2011). Conversely, pax6 may
play a role in activating foxe3 (Thakurela et. al., 2016). Our model situates rax1 and
foxe3 downstream of both six3 and pax6; therefore, foxe3 expression is driven by pax6
and six3 either with rax1 as an intermediary, or directly via a combination of indirect
routes. It is possible that one indirect route involves otx2 and pax6. Ogino et. al. (2008)
suggests pax6 is controlling foxe3 expression indirectly by regulation of otx2.
Alternatively, pax6 could be involved in combinatorial activation with pitx3 which has
been found to be a direct regulator of foxe3 (Ahmad et. al., 2013).

When rax1 is knocked down via morpholino-mediated translation inhibition, a
complete loss of foxe3 expression is the outcome. Martinez-de Luna et. al., (2010) has
found that the rax1 promoter/enhancer possesses binding sites for sox, its, and pou
transcription factors. In isolation none of these is sufficient to recapitulate rax1
expression domain. A further element is required, namely forked binding element (FBE)
which suggests that foxe3, a forkhead box transcription factor, may be able to regulate
rax1. When the forked binding element is removed, rax1 expression is lost (Martinez-de
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Luna et. al., 2010). This suggest that there must be some feedback mechanism
between rax1 and foxe3, where both regulate each others’ expression. A suite of rescue
experiments were performed to confirm this relationship. When pm298 (an anti-rax1
morpholino plasmid) mRNA was co-injected with rax1 morpholino, the expression of
foxe3 was restored in the injected side, and more so, was slightly over-expressed.
Similarly, when rax1 is over-expressed via rax1 mRNA injections, the expression of
foxe3 in lens is slightly enhanced. However, when either pax6 or six3 mRNA is coinjected with rax1 morpholino, foxe3 expression remains lost in both cases. These
findings suggest that there is a direct regulatory role between rax1 and foxe3 since pax6
and six3 are not able to rescue the rax1-MO affect. Although rax1 is appears to be
driving foxe3 expression, the two genes may have a more complex relationship with
parallel factors contributing to their regulatory roles (Figure 3.4); other players such as
otx2, pax6 and pitx3 are known regulators of foxe3, either directly or indirectly (Ahmad
et. al., 2013; Ogino et. al., 2008; Thakurela et. al., 2016).
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Figure 3.4: A summary model of the genes involved in eye development highlighting the
interactions between otx2, foxe3, pitx3, pax6 and rax1 (red). Rax1 has an affect on
foxe3 and appears to regulate foxe3 based on my results. However, It is still unclear if
foxe3 regulates rax1. Pax6, pitx3, and otx2 all have a role in regulating foxe3 (Ahmad
et. al., 2013; Ogino et. al., 2008; Thakurela et. al., 2016). Dashed lines signify a
potential feedback role that is suggested by the data but not yet to be confirmed.
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Rax1 can regulate pitx3 expression

Previous studies have highlighted the significance of pitx3 in Xenopus eye
development, especially its effect on pax6. When pitx3 is over-expressed, the pax6
expression domain is expanded implying a role for pitx3 on pax6 expression in the lens
(Khosrowshahian et al., 2005). Pitx3 knockdown experiments also revealed downregulation of pax6 expression. A similar outcome was observed for rax1, foxe3, and otx2
expression patterns when pitx3 was knocked down (Khosrowshahian et al., 2005).
Conversely, pax6 induces the expression of pitx3 in animal cap explants, but pitx3 is
unable to activate pax6 (Khosrowshahian et al., 2005). Our lab found that knocking
down pax6 resulted in pitx3 expression being diminished in the lens ectoderm. This
suggests that pax6 has a direct regulatory role on pitx3 (Sachani, 2011; Figure 3.5).
However, it does not tell us about the regulatory relationship between pitx3 and rax1.

Rax1 knockdown experiments resulted in loss of pitx3 expression in the lens
placode. Rescue experiments give better insight on the interactive roles indicated
between rax1, pitx3, pax6, and six3. When pm298 mRNA and rax1 morpholino are coinjected, pitx3 expression is completely restored. Similarly, when pax6 or six3 mRNA are
co-injected with rax1 morpholino, pitx3 expression is restored close to normal. These
results suggest that rax1 and pitx3 are regulating each other’s expression since it rax1
is able to inhibit and rescue pitx3 expression and pitx3 reduces rax1 expression
(Khosrowshahian et al., 2005; Current study). Furthermore, pax6 and six3 have a role in
regulating pitx3 expression as they are both able to rescue pitx3 expression when rax1
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is knocked down. My findings confirm that pitx3 is downstream of pax6 and six3 but has
a direct regulatory relationship with pax6 and rax1 (Figure 3.5).

Figure 3.5: A summary model of the genes involved in eye development highlighting the
interactions between pitx3, pax6 and rax1 (red). Rax1 and pitx3 appear to have a
regulatory relationship based on my results and previous findings in our lab
(Khosrowshahian et al., 2005). Pax6 also has a direct relationship with pitx3 where both
are able to regulate each other (Khosrowshahian et al., 2005; Sachani, 2011). Dashed
lines signify a potential feedback role that is suggested by the data but not yet to be
confirmed.
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Rax1 has an indirect affect on 𝞬-crystallin and mafA in eye development

MafA and 𝞬-crystallin are normally expressed in the lens of Xenopus. Pax6
knockdown results in complete loss of the lens specific differentiation target 𝞬-crystallin
(Shimada et. al., 2003; Sachani, 2011). Furthermore, in rax1 morphant Xenopus, 𝞬crystallin expression is down-regulated. However, there are likely parallel factors
causing this effect. Due to rax1’s ability to regulate pax6, mis-expression of pax6
caused by rax1 knockdown could be the cause of mafA inhibition (Figure 3.6).
Activation of mafA by pax6 is crucial for 𝞬-crystallin expression (Takeuchi et. al., 2009).
When pax6 is knocked down, mafA is totally abolished in the lens which results in the
same outcome for 𝞬-crystallin. Similarly, down-regulation of rax1 reduces mafA
expression significantly (current study). In parallel, rax1 mediated activation of foxe3
regulates 𝞬-crystallin expression levels. When foxe3 is over-expressed lens
differentiation is inhibited which is reflected by a complete loss of 𝞬-crystallin
expression. This is most likely the case when rax1 is over-expressed, as we see little 𝞬crystallin expression in the lens.

Clearly there are competing pathways in the regulation of at least some eye field
transcription factors: impaired function of one player in the signal cascade can promote
and repress downstream targets via different indirect routes. The end result of this
combinatorial mix of activation/inhibition routes is summed and spatially delimited by the

76
intermediaries that are present, their concentrations, and the number of cells (size of
field) available. For example, since rax1 has an affect on 𝞬-crystallin and mafA, our
results imply overlapping and competitive signalling cascades to the regulation of
downstream genes. Xenopus embryos unilaterally injected with a cocktail of pm298
mRNA and rax1 morpholino produced a close to normal expression pattern of 𝞬crystallin. Since rax1 is rescued, foxe3 is activated and in turn suppresses 𝞬-crystallin.
However, because pax6 is functioning normally too, it activates mafA which is critical for
𝞬-crystallin expression. This is seen when pax6 mRNA and rax1 morpholino are coinjected, producing a normal expression domain for 𝞬-crystallin. The same outcome is
observed when six3 mRNA rescues 𝞬-crystallin expression against rax1 morpholino.
These findings agree with the assumed hierarchy placing six3 and pax6 upstream of
rax1 and confirm their positioning with respect to direct and indirect action upon
downstream genes (Figure 3.6).
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Figure 3.6: A summary model of the genes involved in eye development highlighting the
placement of rax1, mafA, and 𝞬-crystallin (red). My results suggest that rax1 has an
indirect affect on mafA and 𝞬-crystallin which could be due to combinatorial effects with
pax6 and pitx3. Dashed lines signify a potential feedback role that is suggested by the
data but not yet to be confirmed.

78
Rax1 and otx2 are required to activate one another

Rax1 and otx2 are believed to have some interaction in eye development. Past
studies using in situ hybridization experiments revealed that the two genes have
different expression domains at early stages of eye development, suggesting any
interplay between them must be occurring at later stages (Andreazzoli et al., 1999). It
was also found that rax1 over-expression inhibited otx2 which suggests that otx2 is not
required for eye field specification at early stages of development, but is necessary for
the specification of the anterior neural domains (Andreazzoli et al., 1999).

More recently, rax1 has been identified as having an ultra-conserved element
(UCE) that allows members of the otx family to bind to its regulatory regions (Martinezde Luna et. al., 2010). Zuber et al., (2003) suggested that the expression domains of
otx2 and rax1 are mutually exclusive and proposed an inhibition cycle in his model
where otx2 and rax1 are exclusionary. However, Danno and colleagues (2008) showed
that otx2 and sox2 are required to bind cooperatively to rax1’s ultra-conserved element
for rax1 activation. Furthermore, these studies reveal an increase in rax1 expression
when otx2 is over-expressed, but found that sox2 is required for otx2-induced rax
expression in vivo. Therefore, otx2 and sox2 interact directly with one another and
synergistically activate rax1 expression (Danno et. al., 2008). Interestingly, more recent
studies have revealed that rax1 is essential for otx2 activation in embryonic retina. Otx2
has cis-regulatory region named EELPOT which is an enhancer that contains
consensus sites for homeodomain binding (Muranishi et. al., 2011). Therefore, rax1
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activates otx2 through the EELPOT enhancer. I found that knocking down rax1 reduced
otx2 expression and decreased the diameter of expression in the eye field. This result
could be direct or indirect through reduction of eye field competent cells. However, six3
knockdown experiments proved to have a greater impact on otx2 by causing its
expression to diminish completely at both early and later stages of development
(Sachani, 2011). These findings agree with our proposed model which displays a codependant relationship for otx2 and six3, as well as a direct regulatory relationship
between otx2 and rax1 (Figure 3.7).

Figure 3.7: A summary model of the genes involved in eye development highlighting the
interaction between rax1, otx2, and six3 (red). Rax1 and otx2 activate each other based
on my results along, with relevant literature discussing the relationship between rax1
and otx2 (Danno et. al., 2008; Muranishi et. al., 2011; Martinez-de Luna et. al., 2010).
Six3 and otx2 also appear to have a co-dependant relationship (Sachani, 2011).
Dashed lines signify a potential feedback role that is suggested by the data but not yet
to be confirmed.
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Summary: Eye field signalling model for Xenopus eye development

Zuber and colleague’s (2003) sophisticated model suggested rax1 is upstream of
six3 and pax6. RT-PCR assays on animal caps (cultured ectodermal explants) has
helped establish this model, but this technique does not distinguish eye from general
neural effects. It is also inconsistent with the timing of rax1, pax6, and six3 expression
defined by Zuber using whole embryos as source material. However, my work along
with previous work done in this lab on six3 and pax6, proposes six3 and pax6 to be
upstream of rax1. This was determined through morpholino mediated knockdown
experiments that cause loss of function, as well as through rescue experiments which
involve a rax1 morpholino injected with a anti-rax1 morpholino plasmid (pm298), pax6
or six3. The main difference is that my work utilizes whole embryos which integrates
proliferative and inductive effects, something that cannot be faithfully recapitulated using
animal cap assays.

I have also carried out over-expression experiments which are crucial in
characterizing genetic networks. However, parallel pathways are likely missed using this
technology and what is going on in vivo may be misrepresented. If rax1 over-expression
enhances proliferation, there will be an increase in eye progenitor cells as a result.
Therefore, an indirect effect might be comparable increase in expression of eye field
markers. RT-PCR assays of animal caps serve as sensitive screens that exaggerate
these relationships (Zuber et. al., 2003). Knockdown and rescue experiments provide
new information: rax1 inactivation has no affect on six3 but slightly reduces pax6
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expression only at later stages. Under these circumstances, pax6 and six3 cannot
rescue foxe3 expression, but appear to rescue the eye development process by later
stages. It is evident that rax1, six3, and pax6 are part of a more complicated network
where genes cross-regulate one another, rather than a simple linear signalling cascade.
This has allowed me to develop an alternative proposed model (Figure 3.1).
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CHAPTER 3
Conclusion and Future Directions

Eye field transcription factors and eye field markers are part of a complex,
interconnected cascade that requires genes to turn on and off at the perfect time for eye
development to occur flawlessly. In situ hybridization following knockdown, overexpression, and rescue experiments have shown us that the genes involved in eye
development are operating in a delicate, combinatorial, and nuanced manner to crossregulate and control eye morphogenesis.

My work and work already conducted in our lab has exhibited the ability of eye
field markers to regulate one another both in vivo and in vitro (Khosrowshahian et al.,
2005; Sachani, 2011; Current study). With respect to rax1, pax6, and six3, we see an
overlapping expression domain amongst the eye field transcription factors that allows
each one to regulate the other in a embryonic stage-specific manner. Six3 sets the
cascade for eye development and is required to activate pax6. Pax6 activation helps
maintain six3 and rax1 expression levels and promotes proliferation at later stages.

During later stages, rax1 regulates the number of cells pax6 is expressing. There
is a refining feedback mechanism between rax1 and pax6. Rax1 controls proliferation of
the retinal progenitor cells where six3 expresses (Current study). This suggests that the
three transcription factors are differentially regulating each other during specific stages
of development. My findings along with those of Sachani (2011) confirm the overlapping
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domains of rax1, six3, and pax6 and their regulatory relationship occurring via a stagespecific manner.

Further downstream, rax1 is required to activate foxe3 so that it can promote
proliferation of lens progenitor cells. However, over-expression of foxe3 results in
ectodermal cells remaining in a proliferative state, causing inhibition of differentiation
which leads to loss or delayed crystallin expression (Kenyon et. al., 1999). A foxe3
promoter analysis could lead to a better understanding of foxe3 interactions with other
notable eye field. Currently, there are no studies that have found a rax1 site within the
foxe3 promoter region. A reporter assay would reveal real-time in vivo translational
activity of foxe3 promoter. By using rax1 (or otx2, pax6, pitx3) as a reporter gene on
foxe3 promoter region, we can determine if the reporter gene signals for translation of
endogenous proteins driven from the same promoter.

It is clear that rax1 has a big role to play in eye development, observed by the
small-eye phenotype produced when it is down-regulated, but also its effect on other
eye field markers. Although rax1 down-regulation impairs pitx3 expression, pax6 can
rescue pitx3 which is important for lens induction and retinal development
(Khosrowshashian et. al., 2005). In spite of the fact that mafA expression is slightly
reduced by rax1 knockdown, pax6 has a regulatory role which supports the mafA
activation that is essential for 𝞬-crystallin expression (Takeuchi et. al., 2009). However,
there is a possibility that mafA and rax1 share a direct role in regulation. Since mafA is
important in crystallin activation and regulation, future work should consider knocking

87
down mafA and examining the effect it has on rax1 in eye development. Furthermore,
ChIP sequencing could reveal more about the protein-DNA interactions between mafA
and rax1, as well as determine whether pax6 and pitx3 are involved in regulation. This
will provide a better understanding of the relationship between rax1 and mafA.

Understanding eye development and the hierarchy involved requires more work
to identify the direct or indirect roles between each eye field transcription factor and eye
field marker. We have identified regulatory relationships between many of the genes
involved in eye development, as outlined in our proposed model (Figure 3.1), but some
interactions and effects remain a mystery. It would benefit our model to perform
morpholino mediated-knockdown experiments on other genes such as xoptx2, foxe3,
pax2 and sox2 to determine the effect they have on rax1, pax6 and six3, as well as
other eye field markers. Over-expression and rescue experiments involving these genes
would also tell us more about their interactions with one another. With respect to all the
eye field genes listed in Figure 3.1, performing alternative techniques such as RNA
sequencing (RNA-seq) and chromatin immunoprecipitation sequencing (ChIP-seq)
could potentially reveal more about their regulatory roles both at the RNA, DNA and
protein level. RNA-seq would allow for discovering, quantifying and profiling RNAs and
would be useful in monitoring changes of gene expression at a given time. This would
be very beneficial since the genes involved in eye development are working in a stagespecific manner. ChIP-seq, on the other hand, would be beneficial for identifying protein
interactions with DNA-binding sites since most of the the eye field markers are
transcription factors. The relationship between rax1 and foxe3 or between foxe3 and
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otx2 or pax6 is a great example where potential binding sites may be present and
unveiling them would tell us more about the relationship that exists between these eye
field genes. Furthermore, ChIP-seq could help identify whether the transcription factors
involved in eye development are working alone or are interacting with other outside
factors that could form complexes to activate transcription of lineage specific genes.
This may lead to new information on transcription factor binding sites that were not
previously identified.

Further promoter analysis is possible by conducting a gel mobility shift assay.
Electrophoretic Mobility Shift Assay (EMSA) is a useful technology that evaluates the
degree of specificity of protein binding to DNA probes. This technique would provide
better insight on the protein-DNA binding interactions that already exist for the eye field
transcription factors, and can be used to reveal any alternative binding sites for the
other eye field markers. It would be extremely beneficial to understanding some of the
interactions we’ve examined in our proposed model. A DNA pull-down assay is another
strategy that can be employed to further study protein-DNA complexes. Pull-down
assays selectively extract protein-DNA complexes from a sample and requires the use
of a DNA probe labeled with a high affinity tag to examine the protein-DNA interaction.
Lastly, it would be wise to make use of transgenic Xenopus laevis embryos to gain a
better understanding of the function of genes in eye development and to study of the
regulation of these genes in vivo. Transgenesis in frog embryos can be used to express
wild-type and mutant forms of genes at distinct periods of development and in a specific
location. More specifically, using GFP-tagged reporter genes that are driven by a wild-
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type or mutant promoter could prove very beneficial in transgenic frogs as it would
provide information on their activity during specific development stages in the area of
interest via fluorescence activation. This would provide a more comprehensive
understanding of the stage-specific manner that the eye field markers are turning on/off.

Making use of new and readily available technologies that produce loss of
function effects, allow for in vivo live imaging, and study protein-DNA interactions will
assist in identifying the key roles carried out by genes involved in the development of
the eye.
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APPENDICES
APPENDIX A
Plasmid map
pCS2+ vector cloned with rax1 insert lacking Rax1.1 and Rax1.2 morpholino binding
sites, named pm298.
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APPENDIX B
In Situ Hybridization Protocol
Solutions:
TTw for 100 ml
Tris pH 7.5 1M
NaCl 4 M
Tween 20

5 ml
5 ml
1 ml

MEMPFA for 40 ml (Stocks and fresh solution store in fridge)
MgSO4 1M
40 ul
MOPS pH 7.5 1M
4 ml
EDTA pH 8.0 20 mM
4 ml
Paraformaldehyde 8M
20 ml
RNA Hyb Mix for 100 ml
Formamide
SSC 20X
RNA (bulk yeast)
Denhardts 100X
Tween 20 10%
EDTA 5 mM
Heparin1
1Heparin

50 ml
25 ml
0.1g in 2 ml 50% formamide
1 ml
1 ml
1 ml
0.01 g

Sigma grade II porcine Sigma H-7005 or equivalent

Denhardts 100X for 100 ml
Ficoll 400
PVP
BSA (Fraction V)

2g
2g
2g

SSC 20X for 1 l
NaCl
Na Citrate
pH to 7.0 with NaOH

175.3 g
88.2 g

MAB for 100 ml
Maleic Acid
NaCl
pH to 7.5 with NaOH

1.16 g
0.88 g

APB for 40 ml (optional – depends upon whether BM purple or NBT/BCIP
used)
Tris pH 9.5 1M
4 ml
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MgCl2 1M
NaCl 4M
Tween 20 10%

2 ml
1 ml
400 ul

PBT for 100 ml (for double in situs)
PBS 10x
10 ml
Tween 20 10%
1 ml
PBS 10 x for 1l
NaCl
Na2HPO4
NaH2PO4
pH to 7.0 and autoclave

74.97 g
12.46 g
4.8 g

General Comments
1.
The protocol cannot be accelerated or steps left out (I’ve tried....)
2.
The greatest source of stress for the embryos is getting suctioned out of the vial.
It seems that keeping them just covered with fluid during changes works best.
3.
You have to be meticulous about maintaining an RNase-free environment, fluids,
gloves, desk etc., until after the formamide-containing hybridization steps have been
completed
4.
Change gloves after using the RNase.
5.
NEVER dispose of the used hybridization buffer/probe solution. Probe can be reused dozens of times, and in fact gets better with use for the first few deployments. It is
expensive to make so cherish it and store it fully labeled on the back of the freezer door
6.
Gently mix the antibody tube before use – they tend to settle.
7.
For the colour reaction, if you are using Roche’s BM purple, there is no need to
go through the APB buffer. You can go straight from MAB to 0.5 ml BM Purple. This is
one instance where it pays to remove all liquid between refills.
8.
Bleaching is done under fluorescent lamps and removes the brown pigmentation
over the back, and in the eye. It usually takes between 1 and 2 hours – monitor it.
Magenta phos. pigmentation bleaches from dark purple to bright red, but the other
substrates don’t change much at all over the span of time necessary to bleach
melanocytes.
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Day 1
MeOH
MeOH
MeOH
TTw
TTw

70%
50%
25%

2 min
2 min
2 min
2 min
2 min

Add 1 ul ProK/10ml TTw

5min

MEMPFA
TTw
TTw
TTw
RNA Hyb
RNA Hyb
RNA Hyb and probe

20 min
5 min
5 min
5 min
10 min
1 hr 65oC
o/n 65oC

Day 2
RNA Hyb
10 min 65 oC
2 x SSC
20 min 37 oC
2 x SSC
20 min 37 oC
2 x SSC
20 min 37 oC with 1 ul RNaseA / 5 ml
0.2 x SSC 0,1% Tween 20 1 hr 65 oC
0.2 x SSC 0,1% Tween 20 1 hr 65 oC
0.2 x SSC 0,1% Tween 20 1 hr 65 oC
0.2 x SSC 0,1% Tween 20 10 min R.T.
MAB, 20%Lamb Serum, 2% Roche Blocking Buffer 1 hour R.T.
MAB,
“
“
1:4000 Ab o/n 4 oC
Day 3
MAB
30 min x 10 (fill vials each time)
BM Purple
hours-o/n 4 oC (0.5 ml)
or
APB
5 min
APB, 4.5ul NBT and 3.5 BCIP, or 5 ul Magenta Phos - 2 hours to o/n 4 oC
Keep dark! This is one instance where it pays to remove all liquid between refills.
You have to monitor the reaction. If there is no colour reaction after 3 or 4 hours, you
can probably get away with leaving it in the fridge overnight. If there is still no colour by
the next morning, bring it out to room temperature, keep it dark, and check the reaction
every couple of hours. You can stop the reaction with a rinse or two with MAB followed
by 20 minutes MEMPFA. Magenta Phos can take several days.
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Day 4
If double labeling:
PBT
5 min
PBT
5 min
PBT 4% paraformaldehyde20 min (or MEMFA)
PBT
5 min X 4
PBT
30 min 65 oC
Or skip the fixation, and heat treat directly, or instead wash in
Glycine 100 mM pH 2.2, Tweens-20 0.1%
PBT
5 min X 4

30 min

Then repeat Day 3
Bleach
Formamide 5%, H202

1%, SSC

0.5 X

Finally, take to Methanol or Fix and then take to methanol
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